Where the mon­ey is: Top 100 VCs in­vest­ing in US biotechs dur­ing 2017

It was a big year for US biotechs rais­ing cash from VCs, with flush in­vestors sink­ing a record-break­ing $10.5 bil­lion in­to new and grow­ing com­pa­nies dur­ing 2017. Who’s de­ploy­ing the dol­lars, and where’s the mon­ey com­ing from? We put to­geth­er a fresh list of the top 100 VC firms in­vest­ing in US biotechs, and the da­ta might sur­prise you.

We did this list in 2016 look­ing at 2015 da­ta, and it was one of our most pop­u­lar re­ports of the year. We checked back in, and what we found looked quite dif­fer­ent than our 2015 re­port.

While there’s a lot of re­peat play­ers, we’re al­so see­ing an in­ter­est­ing shift in where big mon­ey is com­ing from. Back in 2015, four of the top five VCs were based in Boston/Cam­bridge. This year, three out of the top five VCs were based in the San Fran­cis­co Bay Area. On­ly one was from Mass­a­chu­setts.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER